Instil Bio (TIL) Revenue & Revenue Breakdown
Instil Bio Revenue Highlights
00
Instil Bio Revenue by Period
Instil Bio Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2024-12-31 | - | 100.00% |
| 2023-12-31 | - | 100.00% |
| 2022-12-31 | - | 100.00% |
| 2021-12-31 | - | -100.00% |
| 2020-12-31 | $138.00K | 100.00% |
| 2019-12-31 | - | - |
Instil Bio generated - in revenue during NA 2024, up 100.00% compared to the previous quarter, and up NaN% compared to the same period a year ago.
Instil Bio Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2025-06-30 | - | 100.00% |
| 2025-03-31 | - | -100.00% |
| 2024-12-31 | $3.99M | 100.00% |
| 2024-09-30 | - | 100.00% |
| 2024-06-30 | - | 100.00% |
| 2024-03-31 | - | -100.00% |
| 2023-12-31 | $7.67M | 100.00% |
| 2023-09-30 | - | 100.00% |
| 2023-06-30 | - | 100.00% |
| 2023-03-31 | - | 100.00% |
| 2022-12-31 | - | 100.00% |
| 2022-09-30 | - | 100.00% |
| 2022-06-30 | - | 100.00% |
| 2022-03-31 | - | 100.00% |
| 2021-12-31 | - | 100.00% |
| 2021-09-30 | - | 100.00% |
| 2021-06-30 | - | 100.00% |
| 2021-03-31 | - | 100.00% |
| 2020-12-31 | - | -100.00% |
| 2020-09-30 | $52.00K | 23.81% |
| 2020-06-30 | $42.00K | -4.55% |
| 2020-03-31 | $44.00K | - |
Instil Bio generated - in revenue during Q2 2025, up 100.00% compared to the previous quarter, and up NaN% compared to the same period a year ago.
Instil Bio Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| SPRO | Spero Therapeutics | $47.98M | $14.19M |
| CCCC | C4 Therapeutics | $20.76M | - |
| SEER | Seer | $14.17M | $4.21M |
| MOLN | Molecular Partners | $7.04M | $2.74M |
| TCRX | TScan Therapeutics | $2.82M | - |
| INO | Inovio Pharmaceuticals | - | - |
| CGTX | Cognition Therapeutics | - | - |
| ABOS | Acumen Pharmaceuticals | - | - |
| TIL | Instil Bio | - | - |
| PEPG | PepGen | - | - |